XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2022   373,873,683      
Balance at beginning of period at Dec. 31, 2022 $ 1,902,677 $ 11 $ 3,155,748 $ (83,382) $ (1,169,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   4,061,015      
Stock issued in connection with equity awards 2,974   2,974    
Shares withheld related to net share settlement (in shares)   (1,281,849)      
Shares withheld related to net share settlement of equity awards (19,167)   (19,167)    
Repurchase of Class A common stock (in shares)   (5,396,617)      
Repurchase of Class A common stock (76,358)   (76,358)    
Stock-based compensation 82,966   82,966    
Other comprehensive loss, net of tax 10,006     10,006  
Net income (loss) (4,518)       (4,518)
Balance at end of period (in shares) at Mar. 31, 2023   371,256,232      
Balance at end of period at Mar. 31, 2023 1,898,580 $ 11 3,146,163 (73,376) (1,174,218)
Balance at beginning of period (in shares) at Dec. 31, 2022   373,873,683      
Balance at beginning of period at Dec. 31, 2022 1,902,677 $ 11 3,155,748 (83,382) (1,169,700)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 75,839        
Balance at end of period (in shares) at Jun. 30, 2023   348,496,613      
Balance at end of period at Jun. 30, 2023 1,517,400 $ 11 2,687,780 (76,530) (1,093,861)
Balance at beginning of period (in shares) at Mar. 31, 2023   371,256,232      
Balance at beginning of period at Mar. 31, 2023 1,898,580 $ 11 3,146,163 (73,376) (1,174,218)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   4,227,973      
Stock issued in connection with equity awards 5,748   5,748    
Shares withheld related to net share settlement (in shares)   (1,503,757)      
Shares withheld related to net share settlement of equity awards (37,436)   (37,436)    
Repurchase of Class A common stock (in shares)   (25,483,835)      
Repurchase of Class A common stock (503,448)   (503,448)    
Stock-based compensation 76,753   76,753    
Other comprehensive loss, net of tax (3,154)     (3,154)  
Net income (loss) 80,357       80,357
Balance at end of period (in shares) at Jun. 30, 2023   348,496,613      
Balance at end of period at Jun. 30, 2023 1,517,400 $ 11 2,687,780 (76,530) (1,093,861)
Balance at beginning of period (in shares) at Dec. 31, 2023   339,886,712      
Balance at beginning of period at Dec. 31, 2023 1,256,329 $ 11 2,134,581 (65,274) (812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   3,936,518      
Stock issued in connection with equity awards 23,429   23,429    
Shares withheld related to net share settlement (in shares)   (1,397,947)      
Shares withheld related to net share settlement of equity awards (80,144)   (80,144)    
Repurchase of Class A common stock (in shares)   (13,466,397)      
Repurchase of Class A common stock (752,224)   (752,224)    
Stock-based compensation 95,253   95,253    
Other comprehensive loss, net of tax (18,622)     (18,622)  
Net income (loss) 236,183       236,183
Balance at end of period (in shares) at Mar. 31, 2024   328,958,886      
Balance at end of period at Mar. 31, 2024 760,204 $ 11 1,420,895 (83,896) (576,806)
Balance at beginning of period (in shares) at Dec. 31, 2023   339,886,712      
Balance at beginning of period at Dec. 31, 2023 1,256,329 $ 11 2,134,581 (65,274) (812,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 546,152        
Balance at end of period (in shares) at Jun. 30, 2024   334,168,646      
Balance at end of period at Jun. 30, 2024 814,836 $ 11 1,172,290 (90,628) (266,837)
Balance at beginning of period (in shares) at Mar. 31, 2024   328,958,886      
Balance at beginning of period at Mar. 31, 2024 760,204 $ 11 1,420,895 (83,896) (576,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock issued in connection with equity awards (in shares)   9,435,913      
Stock issued in connection with equity awards 9,377   9,377    
Shares withheld related to net share settlement (in shares)   (4,226,153)      
Shares withheld related to net share settlement of equity awards (356,336)   (356,336)    
Stock-based compensation 98,354   98,354    
Other comprehensive loss, net of tax (6,732)     (6,732)  
Net income (loss) 309,969       309,969
Balance at end of period (in shares) at Jun. 30, 2024   334,168,646      
Balance at end of period at Jun. 30, 2024 $ 814,836 $ 11 $ 1,172,290 $ (90,628) $ (266,837)